By neutralizing the biochemical triggers of excessive caloric intake and facilitating the organized stabilization of gastric motility through a high-purity molecular complex, Wegovy effectively promotes significant reductions in adiposity markers and systemic metabolic fatigue
Does genetic testing predict GLP-1 response
Administered as a once-weekly subcutaneous injection, it works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, and slows gastric emptying
Contact a healthcare provider or seek emergency care if you experience widespread hives or rash covering large body areas, swelling of face, lips, tongue, or throat, difficulty breathing, wheezing, or chest tightness, dizziness, lightheadedness, or feeling faint, rapid heartbeat accompanied by other symptoms, or severe abdominal pain with injection site swelling
The Journal of Allergy and Clinical Immunology: In Practice , 12(6), 1462-1471
The Loading Phase is an initial period of more frequent administration